Autori: Dellanna Frank
Naslov | Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies (Article) |
Autori | Barratt Jonathan Dellanna Frank Portoles Jose Choukroun Gabriel De Nicola Luca Young James Dimkovic Nada B Reusch Michael |
Info | ADVANCES IN THERAPY, (2023), vol. 40 br. 4, str. 1546-1559 |
Projekat | Astellas Pharma, Inc.; Astellas Pharma, Inc. [DOLOMITES: NCT02021318]; FibroGen, Inc. [SIERRAS: NCT02273726, HIMALAYAS: NCT02052310]; AstraZeneca [ROCKIES: NCT02174731] |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
Naslov | Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies (Article) |
Autori | Barratt Jonathan Dellanna Frank Portoles Jose Choukroun Gabriel De Nicola Luca Young James Dimkovic Nada B Reusch Michael |
Info | ADVANCES IN THERAPY, (2023), vol. 40 br. 4, str. 1546-1559 |
Projekat | Astellas Pharma, Inc. (DOLOMITES); FibroGen, Inc.; AstraZeneca; [NCT02021318]; [NCT02273726]; [NCT02052310]; [NCT02174731] |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: |
Naslov | Cardiovascular Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents for Treatment of Anemia in Patients With Chronic Kidney Disease Incident to or Not Receiving Dialysis: Pooled Subgroup Analysis of Four Phase 3 Studies (Meeting Abstract) |
Autori | Esposito Ciro Barratt Jonathan Dellanna Frank Portoles Jose Choukroun Gabriel De Nicola Luca Reusch Michael Young James Jiletcovici Alina Dimkovic Nada B |
Info | SWISS MEDICAL WEEKLY, (2022), vol. 152 br. , Suppl. 266, str. 23S-24S |
Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
Naslov | Iron Parameters in Patients Treated With Roxadustat for Anemia Associated With Chronic Kidney Disease: Post Hoc Analysis of the Non-Dialysis-Dependent or Incident Dialysis Population From Four Phase 3 Studies (Meeting Abstract) |
Autori | Esposito Ciro Barratt Jonathan Dellanna Frank Portoles Jose Choukroun Gabriel De Nicola Luca Reusch Michael Young James Jiletcovici Alina Dimkovic Nada B |
Info | SWISS MEDICAL WEEKLY, (2022), vol. 152 br. , Suppl. 266, str. 14S-14S |
Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
Naslov | Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents for Treatment of Anemia in Patients with Chronic Kidney Disease Incident to Or Not Receiving Dialysis: Pooled Analysis of Four Phase 3 Studies (Meeting Abstract) |
Autori | Barratt Jonathan Dellanna Frank Portoles Jose Choukroun Gabriel De Nicola Luca Reusch Michael Young James Dimkovic Nada B |
Info | NEPHROLOGY DIALYSIS TRANSPLANTATION, (2022), vol. 37 br. , Suppl. 3, str. I387-I388 |
Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
Naslov | Colestilan in Chronic Kidney Disease Stage 5 Dialysis Patients with Hyperphosphataemia: a Combined Safety Analysis Profile (Meeting Abstract) |
Autori | Dimkovic Nada B Dellanna Frank Spasovski Goce B Wanner Christoph Locatelli Francesco |
Info | NEPHROLOGY DIALYSIS TRANSPLANTATION, (2014), vol. 29 br. , Suppl. 3, str. 384-384 |
Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
Naslov | The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study (Article) |
Autori | Locatelli Francesco Spasovski Goce B Dimkovic Nada B Wanner Christoph Dellanna Frank Pontoriero Giuseppe |
Info | NEPHROLOGY DIALYSIS TRANSPLANTATION, (2014), vol. 29 br. 5, str. 1061-1073 |
Projekat | Mitsubishi Pharma Europe Ltd. |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |